These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24917005)

  • 1. [Risk factors for cardiotoxicity during fluorouracil and cisplatin combination chemotherapy].
    Kaise M; Yoshino M; Nagai H; Sasaki S; Okura Y; Maruyama Y
    Gan To Kagaku Ryoho; 2014 May; 41(5):601-4. PubMed ID: 24917005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport].
    Shen L; Xu JM; Feng FY; Jiao SC; Wang LW; Li J; Guan ZZ; Qin SK; Wang JJ; Yu SY; Wang YJ; Jin YN; Tao M; Zheng LZ; Pan LX
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):295-300. PubMed ID: 23985260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
    Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
    Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
    Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
    Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
    Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
    Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity of 5-fluorouracil.
    Collins C; Weiden PL
    Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of cisplatin-based chemotherapy in advanced non-small cell lung cancer patients.
    Demkow U; Stelmaszczyk-Emmel A
    Respir Physiol Neurobiol; 2013 Jun; 187(1):64-7. PubMed ID: 23548823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
    Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
    Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose FP therapy for advanced and recurrent gastric cancer].
    Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center.
    Khan MA; Masood N; Husain N; Ahmad B; Aziz T; Naeem A
    J Pak Med Assoc; 2012 May; 62(5):430-4. PubMed ID: 22755303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous cisplatin and 5-fluorouracil as second-line treatment of head and neck cancer.
    Merlano M; Grimaldi A; Brunetti I; Modenesi M; Scala M; Margarino G; Scasso F; Santelli A; Castiglia G; Pallestrini E
    Cancer Treat Rep; 1987 May; 71(5):485-8. PubMed ID: 3567974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, comparative study of combination chemotherapies in advanced gastric cancer: 5-fluorouracil and cisplatin (FP) versus 5-fluorouracil, cisplatin, and 4'-epirubicin (FPEPIR). Kyoto Research Group for Chemotherapy of Gastric Cancer (KRGCGC).
    Anticancer Res; 1992; 12(6B):1983-8. PubMed ID: 1295444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significant role of cisplatin and 5-FU combination chemotherapy for first-line intensive treatment for advanced esophageal cancer].
    Matsui S; Iwazawa T; Yano H; Tono T; Nakano Y; Kanoh T; Kinuta M; Monden T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1608-11. PubMed ID: 11707991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of consciousness disorder induced by the syndrome of inappropriate secretion of antidiuretic hormone following cisplatin and 5-fluorouracil chemotherapy in a patient with esophageal cancer].
    Endo C; Takagawa R; Chiba T; Kawamoto M; Konishi T; Honma Y; Minami Y; Watanabe J; Morita T; Mogaki M; Masui H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2130-2. PubMed ID: 24394036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience of intermittent administration of 5-FU and CDDP to patients with advanced and recurrent gastric cancer].
    Sekikawa K; Anzai K; Ishihata R; Yamaki T; Ohki S; Kimijima I; Takenoshita S
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):825-8. PubMed ID: 11432352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.